VEGF is increased in serum but not in spinal cord from patients with amyotrophic lateral sclerosis

NeuroReport

Volumn 13, Issue 17, 2002, Pages 2199-2201

  Nygren, Ingela ^b   Larsson, Anders ^a   Johansson, Anders ^b   Askmark, Håkan ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b NONE

Author keywords

ALS; ELISA; Postmortem spinal cord; Serum; VEGF

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPINAL CORD; TISSUE HOMOGENATE;

ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; ANOXIA; ASTROCYTES; ENDOTHELIAL GROWTH FACTORS; EPENDYMA; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MALE; MIDDLE AGED; MOTOR NEURONS; SPINAL CORD; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0037016172     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200212030-00007     Document Type: Article

References (23)

1. Kuncl RW, Crawford TO, Rothstein JD et al. Motor neuron diseases. In: Asbury AK, McKhann GM, McDonald WI (eds). Diseases of the Nervous System. Philadelphia: WB Saunders; 1992, pp. 1179-1208.
2. Appell SH. Ann Neurol 10, 499-505 (1981).
3. Martin JE. Neurotrophic factors and neurodegeneration. In: Leigh PN and Swash M (eds). Motor Neuron Disease Biology and Management. London: Springer-Verlag; 1995, pp. 241-258.
4. Koliatssos VE, Cayoutte MH, Berkemeier LR et al. Proc Natl Acad Sci USA 91, 3304-3308 (1994).
5. Henderson CE, Philips HS, Pollock Ra et al. Science 266, 1062-1064 (1994).
6. Yah Q, Matheson C and Lopez OT. Nature 373, 341-344 (1995).
7. Meininger V. Amyotrophic Lateral Sclerosis 2(Suppl), 15-18 (2001).
8. Carmeleit P. Nature Med 6, 389-395 (2000).
9. Ferrara N and Alitalo K. Nature Med 5, 1359-1364 (1999).
10. Sondell M, Lunborg G and Kanje M. J Neurosci 19, 5731-5740 (1999).
11. Jin KL, Mao XO and Greenberg DA. Proc Natl Acad Sei USA 97, 10242-10247 (2000).
12. Scratzberger P, Scratzberger G, Silver M et al. Nature Med 6, 405-413 (2000).
13. Oosthuyse B, Moons L, Storkebaum E et al. Nature Genet 28, 131-138 (2001).
14. Brooks BR. J Neurol Sci 124, 96-107 (1994).
15. Cederbaum JM and Stambler N. J Neurol Sci 152(Suppl. 1), 1-9 (1997).
16. Plate KH. J Neuropathol Exp Neurol 58, 313-320 (1999).
17. Behzadian MA, Wang XL, Shabrawey M et al. Glia 24, 216-225 (1998).
18. Skene JHP and Cleveland DW. Nature Genet 28, 107-108 (2002).
19. Shaw PJ and Eggett JC. J Neurol 247(Suppl. 1), 17-27 (2000).
20. Slevin M, Krupinski J, Slowik A et al. Stroke 31, 1863-1870 (2000).
21. Borisov AB, Huang SK and Carlsson BM. Anat Rec 258, 292-304 (2000).
22. Karpati G, Klassen G and Tanser P. Can J Neurol Sci 6, 105-112 (1979).
23. Rissanen TT, Vajanto I, Hiltunen MO et al. Am J Pathol 160, 1393-1403 (2002).